Coronavirus Vaccine Tracker
18 Jan, 2021
Vaccines typically require years of research and testing before reaching the clinic, but in 2020, scientists embarked on a race to produce safe and effective coronavirus vaccines in record time. Researchers are currently testing 68 vaccines in clinical trials on humans, and 20 have reached the final stages of testing. At least 90 preclinical vaccines are under active investigation in animals.
| New additions and recent updates | |
|---|---|
| Jan. 14 | The Israel Institute for Biological Research moves to Phase 2. |
| Jan. 13 | Brazil announces Sinovac’s vaccine has an efficacy of just over 50 percent. |
| Jan. 12 | California-based Arcturus moves to Phase 2. |
| Jan. 12 | Canada’s VIDO enters Phase 1/2. |
| Jan. 6 | The European Union authorizes Moderna’s vaccine. |
| Jan. 4 | Israel authorizes Moderna’s vaccine. |
| Jan. 4 | Taiwan’s Medigen moves to Phase 2. |
| Jan. 3 | India authorizes a vaccine from Bharat Biotech. |
| Jan. 4 | Mexico authorizes the Oxford-AstraZeneca vaccine. |
| Jan. 3 | India and Argentina authorize the Oxford-AstraZeneca vaccine. |
| Jan. 3 | India’s Zydus Cadila moves to Phase 3. |
For reading full text click the link.